All Stories

  1. Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis

    Article • Journal of Dermatological Treatment, April 2019, Taylor & Francis

    Dr Francesco Carubbi

  2. Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls

    Article • Current Rheumatology Reviews, December 2018, Bentham Science Publishers

    Dr Francesco Carubbi, Onorina Berardicurti

  3. Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities

    Article • Journal of Immunology Research, November 2018, Hindawi Publishing Corporation

    Dr Francesco Carubbi, Onorina Berardicurti

  4. Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al

    Article • Arthritis Care & Research, February 2017, Wiley

    Dr Francesco Carubbi

  5. Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Dr Francesco Carubbi

  6. Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study

    Article • Clinical & Experimental Immunology, March 2016, Wiley

    Dr Francesco Carubbi

  7. Rheumatoid factor in Sjögren's syndrome: The need to target MALT tissue for preventing lymphoma

    Article • Arthritis & Rheumatology, January 2016, Wiley

    Dr Francesco Carubbi

  8. Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare

    Article • International Journal of Immunopathology and Pharmacology, December 2015, SAGE Publications

    Dr Francesco Carubbi

  9. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution

    Article • Autoimmunity Reviews, November 2015, Elsevier

    Dr Francesco Carubbi

  10. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts

    Article • Arthritis Research & Therapy, September 2015, Springer Science + Business Media

    Dr Francesco Carubbi

  11. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis

    Article • Expert Opinion on Biological Therapy, September 2015, Informa Healthcare

    Dr Francesco Carubbi

  12. Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis?

    Article • Arthritis Research & Therapy, August 2015, Springer Science + Business Media

    Dr Francesco Carubbi

  13. Use of Rituximab in the Management of Sjögren’s Syndrome

    Article • Current Treatment Options in Rheumatology, July 2015, Springer Science + Business Media

    Dr Francesco Carubbi

  14. Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies

    Article • Cytotherapy, July 2015, Elsevier

    Dr Francesco Carubbi

  15. Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature

    Article • Journal of Medical Case Reports, June 2015, Springer Science + Business Media

    Dr Francesco Carubbi

  16. Erratum to “Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren’s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study” [Semin Arthritis Rheum 44 (2014) 314–324]

    Article • Seminars in Arthritis and Rheumatism, June 2015, Elsevier

    Dr Francesco Carubbi

  17. Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease

    Article • Autoimmunity Reviews, May 2015, Elsevier

    Dr Francesco Carubbi

  18. The Role of IL-1βin the Bone Loss during Rheumatic Diseases

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    Dr Francesco Carubbi

  19. T Regulatory and T Helper 17 Cells in Primary Sjögren’s Syndrome: Facts and Perspectives

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    Dr Francesco Carubbi

  20. Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: A new era for therapeutic targeting?

    Article • Autoimmunity Reviews, December 2014, Elsevier

    Dr Francesco Carubbi

  21. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study

    Article • Seminars in Arthritis and Rheumatism, December 2014, Elsevier

    Dr Francesco Carubbi

  22. Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features

    Article • Arthritis Research & Therapy, September 2014, Springer Science + Business Media

    Dr Francesco Carubbi

  23. Methotrexate: an old new drug in autoimmune disease

    Article • Expert Review of Clinical Immunology, September 2014, Taylor & Francis

    Dr Francesco Carubbi

  24. CD4−CD8− T-cells in primary Sjögren's syndrome: Association with the extent of glandular involvement

    Article • Journal of Autoimmunity, June 2014, Elsevier

    Dr Francesco Carubbi

  25. Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study

    Article • Journal of Autoimmunity, June 2014, Elsevier

    Dr Francesco Carubbi

  26. Potential of stem cells in the treatment of rheumatic disease

    Article • International Journal of Clinical Rheumatology, April 2014, OMICS Publishing Group

    Dr Francesco Carubbi

  27. Methotrexate in Rheumatoid Arthritis: Optimizing Therapy Among Different Formulations. Current and Emerging Paradigms

    Article • Clinical Therapeutics, March 2014, Elsevier

    Dr Francesco Carubbi

  28. Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis

    Article • Fibrogenesis & Tissue Repair, January 2014, Springer Science + Business Media

    Dr Francesco Carubbi

  29. Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series

    Article • Clinical Rheumatology, September 2013, Springer Science + Business Media

    Dr Francesco Carubbi

  30. Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy

    Article • Autoimmunity Reviews, May 2013, Elsevier

    Dr Francesco Carubbi

  31. Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS

    Article • Expert Review of Clinical Immunology, May 2013, Taylor & Francis

    Dr Francesco Carubbi

  32. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

    Article • Angiogenesis, February 2013, Springer Science + Business Media

    Dr Francesco Carubbi

  33. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Dr Francesco Carubbi

  34. Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation?

    Article • Autoimmunity Reviews, August 2011, Elsevier

    Dr Francesco Carubbi